Metraipolis › archive › dc_da11d453e68f

Anticancer Properties of Imidazolium Salt Derivatives: Current Advances and Therapeutic Perspectives — Europe PMC PMID:42649871

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42649871
DOI
10.3390/cancers18162556
License (as archived)
solo-consultazione
Archived
2026-10-16T22:30:13.613Z
SHA-256 of the archived text
f41fe7d34da943d70aeaadd412c0bb8179573bdd481adb7396f39883f3bdae84
Stable URL of this page
https://metraipolis.com/documento/dc_da11d453e68f

How to cite

Anticancer Properties of Imidazolium Salt Derivatives: Current Advances and Therapeutic Perspectives — Europe PMC PMID:42649871 — Europe PMC (en), https://europepmc.org/article/MED/42649871 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_da11d453e68f (Metraipolis archive dc_da11d453e68f, sha256 f41fe7d34da943d70aeaadd412c0bb8179573bdd481adb7396f39883f3bdae84)
BibTeX
@misc{dcda11d453e68f,
  title = {Anticancer Properties of Imidazolium Salt Derivatives: Current Advances and Therapeutic Perspectives — Europe PMC PMID:42649871},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42649871},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_da11d453e68f; sha256 f41fe7d34da943d70aeaadd412c0bb8179573bdd481adb7396f39883f3bdae84},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42649871. Agents can read the archived copy with the MCP tool read_document.